Finance
Dendritic Nanotechnologies to develop ovarian cancer diagnostic and therapeutic delivery system
Published in Drug Week, November 3rd, 2006
The project will use DNT's Priostar dendrimers to develop a new generation of targeted diagnostic and therapeutic delivery technology for the early detection and treatment of epithelial ovarian cancer. Annual U.S. expenditures for medical treatment of ovarian cancer are approximately $1.5 billion.
This marks the first time that dendrimer nanostructures will be used as both a diagnostic tool and a vehicle to deliver higher concentrations of therapeutic agents to cancerous cells....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-11-03)
More Articles from Drug Week
- Dermatology
Phase III data show Humira statistically superior to methotrexate in psoriasis - Drug Development
Kyowa Hakko grants Keryx exclusive rights to anticancer agent UCN-01 - Drug Development
Positive preclinical results show fat reduction capability for Neuren's compound NNZ-3006 - HIV/AIDS Therapy
Human Genome Sciences reports positive results of phase I CCR5 mAb trial in HIV patients - Market Analysis
Effective product solutions are key drivers of European respiratory diseases market - Aneurysm Therapy
New findings from University of Hong Kong, Department of Surgery in the area of aneurysm therapy published - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
